Dr. Panagiotis Afouxenidis is a Dallas, Texas based Periodontics who is specialized in Periodontology. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Panagiotis Afouxenidis is 39760 for Periodontology in Texas. His current practice location is 3600 Mckinney Ave Ste 230, Dallas. Patients can reach him at 469-463-8340.
Dr. Panagiotis Afouxenidis is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Dr. Panagiotis Afouxenidis speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1891459707
NPI Enumeration Date:
26 Oct, 2021
NPI Last Update On:
23 Jan, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Panagiotis Afouxenidis are as mentioned below.
License Number
Specialization
State
Status
39760
Periodontology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7425 La Vista Dr Apt 2034, Dallas, Texas
Zip:
75214-4472
Phone Number:
469-463-8340
Patients can reach Dr. Panagiotis Afouxenidis at 3600 Mckinney Ave Ste 230, Dallas, Texas or can call to book an appointment on 469-463-8340. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 March, 2025.